Wednesday, 21 December 2011 00:33

Aliskiren trial terminated for lack of beneficial effects

Written by 
Rate this item
(1 Vote)

In a stunning development, Novartis said Tuesday that it will terminate the late-stage ALTITUDE study investigating Rasilez (aliskiren) in patients with type 2 diabetes and renal impairment on the recommendation of an independent data monitoring committee.

Read more on our partner site UKidney

Read 1133 times Last modified on Wednesday, 21 December 2011 00:40
Published in ISN blog
Tagged under
Luca Segantini

Hi, as ISN Executive Director I am here to ensure that all trains come to the station on time and that passengers are satisfied. Please do get in touch on lsegantini@theisn.org to comment, share or simply to talk.

Website: www.theisn.org/isnnews/author/64-luca-segantini

Latest from Luca Segantini

More in this category: « ISN update course and regional workshop in Dubai KDIGO first clinical practice conference Shanghai »

Leave a comment

Make sure you enter the (*) required information where indicated.

[b] [i] [u] [s] [url] [quote] [code] [img]   

Comments (0)

back to top

ISN Leaders

  • ISN Secretary General Adeera Levin is Professor of Medicine and Head Divsision of Nephrology at the University of British Columbia in Vancouver, Canada and a consultant nephrologist based at St Paul's Hospital, Providence Health Care.

  • David Harris is a nephrologist in Sydney Australia, and Chair of the ISN Fellowship Program, Publications and Education Committees.

  • Dwomoa Adu. MD. FRCP

    Honorary Consultant Nephrologist. Korle Bu Hospital. Accra. Ghana

    My clinical research is oriented towards assessing disease activity and damage in patients with immune mediated renal diseases and developing clinical trials of therapy. Current research interests are on the prevalence and causes of chronic kidney disease and the genetic basis of chronic kidney disease in Africa.

  • ISN President-Elect Giuseppe Remuzzi is Professor of Nephrology, Director of the Immunology and Clinical Transplantation Department and Nephrology and Dialysis Division at the Ospedali Riuniti di Bergamo, Italy.
  • ISN President John Feehally is a Consultant Nephrologist at Leicester General Hospital and Honorary Professor of Renal Medicine at the University of Leicester, UK.

  • is Professor of Medicine at University Hospital of Gent in Belgium and is currently Chair of the ISN Global Outreach Continuing Medical Education Program.

  • ISN GO Chair William Couser is Affiliate Professor of Medicine at the University of Washington in Seattle, was the Belding H Scribner Professor of Medicine and Head of the Nephrology Division and is a former ISN and ASN President.

Global Operations Center
Rue des Fabriques 1
1000 Brussels, Belgium
Tel: +32 2 808 04 20
Fax: +32 2 808 4454
Email contact

Americas Operations Center
340 North Avenue 3rd Floor
Cranford, NJ 07016-2496, United States
Tel: +1 567 248 9703
Fax: +1 908 272 7101
Email contact